Home » Topics » Regulatory » Patents

Patents
RSS

BASF focuses on dolastatin derivatives

Feb. 17, 1997

Novel anti-HIV compounds disclosed by Novartis

Feb. 17, 1997

TK signal transduction modulators claimed by Sugen

Feb. 17, 1997

TK inhibitors disclosed by RCT

Feb. 14, 1997

BASF prepares dolastatin derivatives

Feb. 14, 1997

Zeneca describes ET antagonists

Feb. 14, 1997

Retinoid series for cancer

Feb. 14, 1997

Anti-factor Xa compounds disclosed by RPR

Feb. 14, 1997

X-ray contrast agents from Schering AG

Feb. 14, 1997

Human Genome Sciences describes MCP-4 polypeptide

Feb. 14, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...